Secondary solid cancer screening following hematopoietic cell transplantationYoshihiro Inamoto, Navneet S. Majhail, Robert J. Hayashi et al.|Bone Marrow Transplantation|2015Cited by 185
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular TherapyMohamed A. Kharfan‐Dabaja, Marcie Riches, Ambuj Kumar et al.|Transplantation and Cellular Therapy|2021Cited by 180
Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMTZachariah DeFilipp, Bronwen E. Shaw, Rafael F. Duarte et al.|Biology of Blood and Marrow Transplantation|2016Cited by 64
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 UpdateSeth J. Rotz, Rachel Phelan, Neel S. Bhatt et al.|Transplantation and Cellular Therapy|2024Cited by 62
Comparative Analysis of Calcineurin Inhibitor–Based Methotrexate and Mycophenolate Mofetil–Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic TransplantationSaurabh Chhabra, Betty K. Hamilton, Ying Liu et al.|Biology of Blood and Marrow Transplantation|2018Cited by 51